The FDA has approved Navidea Biopharmaceutical's (NAVB -7.4%) Lymphoseek injection, a...


The FDA has approved Navidea Biopharmaceutical's (NAVB -7.4%) Lymphoseek injection, a radioactive imaging agent meant to help doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing surgery to remove the lymph nodes. The drug, which is the first new lymph-node mapping agent approved in more than 30 years, is injected into the tumor area and later, using a hand-held radiation detector, identifies lymph nodes that have taken up Lymphoseek.

From other sites
Comments (8)
  • gary8853
    , contributor
    Comments (12) | Send Message
     
    Finally! Should be a good revenue "shot in the arm" for this small company.
    13 Mar 2013, 02:02 PM Reply Like
  • sablya
    , contributor
    Comments (18) | Send Message
     
    Looks like they lowered the boom on this one. 19M short shares looking for a way out. Looks like a good squeeze candidate to me.
    13 Mar 2013, 02:24 PM Reply Like
  • garyg77
    , contributor
    Comments (2) | Send Message
     
    Why the drop?
    13 Mar 2013, 02:31 PM Reply Like
  • rshea57
    , contributor
    Comments (2) | Send Message
     
    Agree with You Gary.Potentially $ 600 million dollar shot in the arm.Why is the stock tanking today?
    13 Mar 2013, 02:31 PM Reply Like
  • 6675821
    , contributor
    Comments (2) | Send Message
     
    Lots of people wondering. Shorts adding to positions?
    13 Mar 2013, 03:00 PM Reply Like
  • gary8853
    , contributor
    Comments (12) | Send Message
     
    Stock dropping due to "Buy the rumor, sell the news". Someone got in really cheaply and is now taking profits. Stock should move up once this selling is done. I too agree that it has major squeeze potential.
    13 Mar 2013, 03:00 PM Reply Like
  • Edward Yoxen
    , contributor
    Comments (320) | Send Message
     
    In fact if you look at the price trend after the announcement, it began falling quite sharply for an hour or so, which suggests that some holders of shares were taking their profits, and perhaps also hoping to push the price down, but by about 3.30 pm the price started moving up again, suggesting that enough new buyers had come into the market to push the price back up. It will be interesting to see what happens after the conference call.
    13 Mar 2013, 05:46 PM Reply Like
  • pjg69ny
    , contributor
    Comments (431) | Send Message
     
    well we are even lower now with 2.40 price what is the issue now?
    24 Apr 2013, 10:44 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs